LARVOL is pleased to present a moderated discussion with top oncologists following the ESMO Congress 2021. In the video below, Dr. Shilpa Gupta, Dr. Deepak Kilari and Dr. Bradley McGregor discuss the practice-changing impact of ESMO presentations in GU Cancers.
On September 19th, 2021, LARVOL hosted an Oncology Panel to discuss the top Genitourinary Cancer clinical trial abstracts presented during the ESMO Congress 2021 , held on September 16-21, 2021. Dr. Shilpa Gupta from Cleveland Clinic Taussig Cancer Institute moderated the discussion between GU Cancer experts Dr. Deepak Kilari from Medical College of Wisconsin and Dr. Bradley McGregor from Dana-Farber Cancer Institute.
The discussion covered ESMO GU Abstracts:
Watch this video for the full discussion:
The advent of precision oncology is marked by many new changes and improvements in diagnostic, prognostic and treatment methods for cancer patients. Researchers looking to bring new drugs to market are now also privy to a vast database of material from previously conducted studies thanks to a push forward in research collaborations and the creation of shared data hubs.